Clearview Diagnostics, Inc. to Develop Breast Cancer Screening Technology

Share this content:

the Cancer Therapy Advisor take:

The leading cause of cancer-related death and disability in women is breast cancer, most notably for younger patients in developing countries. Furthermore, patients in developing countries experience survival rates that are far lower than their counterparts in the United States because of a lack of available diagnostics and treatment. The National Institute of Health (NIH) gave a grant to Clearview Diagnostics, Inc. to develop new breast cancer screening technology that will allow for more widespread diagnosis, and this project hopes to produce a portable self-reading ultrasound device. In order to discern malignant palpable lumps from benign lumps, the low-cost device will use imaging enhancing algorithms and computer-aided detection and diagnosis. Clinical trials will be performed in Southern California county hospitals, which will help determine the specificity and sensitivity of the device. After the $1 million phase I grant, NIH will use the clinical trials to assess the possibility of entering into a phase II grant. Clinical trials would also be held in Jalisco, Mexico to test the device’s effectiveness in a developing country. Since this technology does not require a clinical staff for its usage, some burden on health care systems will be relieved. Clearview Diagnostics, Inc. will be working in collaboration with the Dr. Susan Love Research Foundation.

Do Mammograms Save Lives?
Clearview Diagnostics, Inc. to Develop Breast Cancer Screening Technology
Clearview Diagnostics, Inc. as part of a compendium, announced today the receipt of a grant from the NIH (National Institute of Health) to develop a portable self-reading device for breast cancer screening. Susan Love Research Foundation to develop portable, self-reading ultrasound for breast screening.

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs